Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

View source ↗

Summary

Long-term follow-up updates for subjects who received ICM-203 or matching placebo in knee osteoarthritis. Enrollment is ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ICM-203 (ICM-203)

Snippet

Sponsor: ICM Co. Ltd. | Conditions: Osteoarthritis, Knee | Status: ENROLLING_BY_INVITATION